Barbara Ryan

Barbara Ryan is a seasoned professional with extensive experience in finance and corporate governance. Currently, Barbara serves as a Senior Advisor at EY and holds multiple board positions, including Audit Chair at MiNK Therapeutics, Non Executive Board Director at Indivior, and Board Member roles at Safecor Health and OcuTerra Therapeutics. Barbara is also a Board Member at INVO Bioscience, actively participating in various committees. In addition, Barbara is the founder of Fabulous Pharma Females and Barbara Ryan Advisors, providing capital markets advisory, investor relations, and strategic communications. With a background as Managing Director at Deutsche Bank, Barbara leads the Pharmaceuticals Equity Research Platform. Barbara is also a columnist for Pharmaceutical Executive Magazine, contributing insights on finance since 2008. Educational credentials include a degree in Finance and Economics from the University of Massachusetts Amherst.